Scrip Asks…What Does 2022 Hold For Biopharma? Part 5: Clinical Trials
Decentralization, Diversity And Data Analytics Are Drivers Of Change
Executive Summary
The COVID-19 pandemic drove huge shifts in clinical trial practice and the transformation is expected to continue even after the global health emergency abates. Industry leaders sharing their predictions around clinical development homed in on decentralized trials, digitization and data tools as key topics for 2022.